Yaping Luo

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Rheumatoid Arthritis

Multiple Myeloma

Newly Diagnosed

Top Venues

EJNMMI research

Diagnostics (Basel, Switzerland)

European radiology

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Qingqing Pan, Huaxia Yang, Ziyue Zhou, Min Li, Xu Jiang, Fang Li, Yaping Luo, Mengtao Li
[ 68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis. EJNMMI research 14 (1) (2024)
Qingqing Pan, Huaxia Yang, Ziyue Zhou, Min Li, Xu Jiang, Fang Li, Yaping Luo, Mengtao Li
[ 68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis. EJNMMI research 14 (1) (2024)
Qingqing Pan, Huaxia Yang, Ziyue Zhou, Min Li, Xu Jiang, Fang Li, Yaping Luo, Mengtao Li
[ 68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis. EJNMMI research 14 (1) (2024)
Qingqing Pan, Yaping Luo, Xinxin Cao, Jian Li, Jun Feng
Bing-Neel Syndrome and Coexisting Pituitary Macroadenoma in a Patient with Waldenström Macroglobulinemia Revealed by 18 F-FDG and 68 Ga-Pentixafor PET/CT. Diagnostics (Basel, Switzerland) 13 (7) (2023)
Jianan Zhang, Ruixue Cui, Jian Li, Xinxin Cao, Yaping Luo
Characterizing Rosai-Dorfman disease with [ 18 F]FDG PET/CT: a retrospective analysis of a single-center study. European radiology (2023)
Qingqing Pan, Yaping Luo, Xinxin Cao, Jian Li, Fang Li
68 Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease. Diagnostics (Basel, Switzerland) 13 (5) (2023)
Jianan Zhang, Ruixue Cui, Jian Li, Xinxin Cao, Yaping Luo
Correction: Characterizing Rosai-Dorfman disease with [ 18 F]FDG PET/CT: a retrospective analysis of a single-center study. European radiology (2023)
Qingqing Pan, Yaping Luo, Xinxin Cao, Jian Li, Fang Li
68 Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease. Diagnostics (Basel, Switzerland) 13 (5) (2023)
Hongzhe Zhang, Yaping Luo
Cardiac Metastasis of Malignant Melanoma Detected by 18 F-FDG PET/CT. Diagnostics (Basel, Switzerland) 13 (13) (2023)
Yaping Luo, Qingqing Pan, Ziyue Zhou, Min Li, Yanping Wei, Xu Jiang, Huaxia Yang, Fang Li
68 Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study. Radiology (2023)
Qiao Yang, Yaping Luo, Yan Zhang, Wei Zhang, Daobin Zhou, Fang Li
Baseline [ 18 F]FDG PET/CT may predict the outcome of newly diagnosed follicular lymphoma in patients managed with initial "watch-and-wait" approach. European radiology 32 (8) (2022)
Meiqi Wu, Qingqing Pan, Yaping Luo
Different Uptake of 68 Ga-FAPI and 18 F-FDG in Lymphadenopathy Caused by Angioimmunoblastic T-Cell Lymphoma in a Patient with Colon Cancer. Diagnostics (Basel, Switzerland) 12 (9) (2022)
Qingqing Pan, Xinxin Cao, Yaping Luo, Jian Li, Fang Li
Semi-quantitative measurements of chemokine receptor 4-targeted 68Ga-pentixafor PET/CT in response assessment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. EJNMMI research 11 (1) (2021)
Qingqing Pan, Yaping Luo, Yan Zhang, Long Chang, Ji Li, Xinxin Cao, Jian Li, Fang Li
Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG. EJNMMI research 10 (1) (2020)
Yaping Luo, Qingqing Pan, Wen Zhang
IgG4-related disease revealed by 68Ga-FAPI and 18F-FDG PET/CT. European journal of nuclear medicine and molecular imaging 46 (12) (2019)
Qingqing Pan, Xinxin Cao, Yaping Luo, Jian Li, Jun Feng, Fang Li
Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT. European journal of nuclear medicine and molecular imaging 47 (3) (2019)